Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Autologous Hematopoietic Cell Transplantation in Multiple Sclerosis: Changing Paradigms in the Era of Novel Agents.

Gavriilaki M, Sakellari I, Gavriilaki E, Kimiskidis VK, Anagnostopoulos A.

Stem Cells Int. 2019 Jun 24;2019:5840286. doi: 10.1155/2019/5840286. eCollection 2019. Review.

2.

Brentuximab vedotin and anti-PD1 treatment optimize survival in chemo-refractory Hodgkin lymphoma patients: Real-world data.

Sakellari I, Gavriilaki E, Iskas M, Bousiou Z, Chatziioannidis A, Batsis I, Mallouri D, Constantinous V, Stavroyianni N, Syrigou A, Marvaki A, Pilavaki M, Papaemmanouel S, Anagnostopoulos A.

Hematol Oncol. 2019 Jun 10. doi: 10.1002/hon.2645. [Epub ahead of print] No abstract available.

PMID:
31339579
3.

Early Prediction of Cardiovascular Risk after Hematopoietic Cell Transplantation: Are We There Yet?

Gavriilaki E, Gkaliagkousi E, Sakellari I, Anyfanti P, Douma S, Anagnostopoulos A.

Biol Blood Marrow Transplant. 2019 Jul 13. pii: S1083-8791(19)30444-6. doi: 10.1016/j.bbmt.2019.07.012. [Epub ahead of print] Review.

PMID:
31310812
4.

Linking Complement Activation, Coagulation, and Neutrophils in Transplant-Associated Thrombotic Microangiopathy.

Gavriilaki E, Chrysanthopoulou A, Sakellari I, Batsis I, Mallouri D, Touloumenidou T, Papalexandri A, Mitsios A, Arampatzioglou A, Ritis K, Brodsky RA, Mitroulis I, Anagnostopoulos A.

Thromb Haemost. 2019 Sep;119(9):1433-1440. doi: 10.1055/s-0039-1692721. Epub 2019 Jul 2.

PMID:
31266080
5.

Isolated Extramedullary Relapse as a Poor Predictor of Survival after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia.

Sakellari I, Gavriilaki E, Batsis I, Mallouri D, Gavriilaki M, Apostolou C, Iskas M, Voutiadou G, Bouziana S, Bousiou Z, Constantinou V, Masmanidou M, Sotiropoulos D, Yannaki E, Lalayanni C, Pilavaki M, Chatziioannou K, Papayannopoulos S, Anagnostopoulos A.

Biol Blood Marrow Transplant. 2019 May 22. pii: S1083-8791(19)30329-5. doi: 10.1016/j.bbmt.2019.05.018. [Epub ahead of print]

PMID:
31128329
6.

Neurological adverse events post allogeneic hematopoietic cell transplantation: major determinants of morbidity and mortality.

Sakellari I, Gavriilaki E, Papagiannopoulos S, Gavriilaki M, Batsis I, Mallouri D, Vardi A, Constantinou V, Masmanidou M, Yannaki E, Smias C, Geroukis T, Kazis D, Kimiskidis V, Anagnostopoulos A.

J Neurol. 2019 Aug;266(8):1960-1972. doi: 10.1007/s00415-019-09372-3. Epub 2019 May 13.

PMID:
31087160
7.

Skewing of the T-cell receptor repertoire in patients receiving rituximab after allogeneic hematopoietic cell transplantation: what lies beneath?

Papalexandri A, Karypidou M, Stalika E, Kotta K, Touloumenidou T, Zerva P, Paleta A, Mallouri D, Batsis I, Sakellari I, Kotsianidis I, Anagnostopoulos A, Hadzidimitriou A, Margaritis D, Stamatopoulos K.

Leuk Lymphoma. 2019 Jul;60(7):1685-1692. doi: 10.1080/10428194.2018.1543881. Epub 2019 Jan 17.

PMID:
30652530
8.

Guided Assembly of Block Copolymers in Three-Dimensional Woodpile Scaffolds.

Choi J, Koo S, Sakellari I, Kim H, Su Z, Carter KR, Farsari M, Grigoropoulos CP, Russell TP.

ACS Appl Mater Interfaces. 2018 Dec 12;10(49):42933-42940. doi: 10.1021/acsami.8b17172. Epub 2018 Nov 30.

PMID:
30444346
9.

BEAC (carmustine, etoposide, cytarabine, and cyclophosphamide) in autologous hematopoietic cell transplantation: a safe and effective alternative conditioning regimen for Hodgkin and non-Hodgkin lymphoma.

Sakellari I, Gavriilaki E, Bouziana S, Constantinou V, Mallouri D, Vardi A, Marvaki A, Batsis I, Sotiropoulos D, Anagnostopoulos A.

Bone Marrow Transplant. 2019 Jun;54(6):921-923. doi: 10.1038/s41409-018-0395-y. Epub 2018 Nov 8. No abstract available.

PMID:
30410083
10.

Reader response: Usefulness of ADAMTS13 to predict response to recanalization therapies in acute ischemic stroke.

Gavriilaki M, Sakellari I, Kimiskidis V.

Neurology. 2018 Nov 6;91(19):898-899. doi: 10.1212/WNL.0000000000006464. No abstract available.

PMID:
30397045
11.

Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single-center study.

Sakellari I, Gavriilaki E, Batsis I, Mallouri D, Panteliadou AK, Lazaridou A, Vardi A, Constantinou V, Yannaki E, Papalexandri A, Kaloyannidis P, Smias C, Anagnostopoulos A.

J Clin Apher. 2018 Dec;33(6):654-660. doi: 10.1002/jca.21660. Epub 2018 Nov 5.

PMID:
30394564
12.

The role of intramolecular charge transfer and symmetry breaking in the photophysics of pyrrolo[3,2-b]pyrrole-dione.

Tasior M, Hassanein K, Mazur LM, Sakellari I, Gray D, Farsari M, Samoć M, Santoro F, Ventura B, Gryko DT.

Phys Chem Chem Phys. 2018 Aug 29;20(34):22260-22271. doi: 10.1039/c8cp03755h.

PMID:
30123919
13.

Transplant-associated thrombotic microangiopathy: Incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation.

Gavriilaki E, Sakellari I, Batsis I, Mallouri D, Bousiou Z, Vardi A, Yannaki E, Constantinou V, Tsompanakou A, Vadikoliou C, Kaloyannidis P, Bamihas G, Anagnostopoulos A.

Clin Transplant. 2018 Sep;32(9):e13371. doi: 10.1111/ctr.13371. Epub 2018 Aug 20.

PMID:
30080283
14.

Positive impact of brentuximab vedotin on overall survival of patients with classical Hodgkin lymphoma who relapse or progress after autologous stem cell transplantation: A nationwide analysis.

Tsirigotis P, Vassilakopoulos T, Batsis I, Bousiou Z, Gkirkas K, Sakellari I, Kaloyannidis P, Roussou P, Pangalis GA, Moschogiannis M, Vassilopoulos G, Repousis P, Megalakaki A, Michalis E, Kalpadakis C, Papadaki HA, Kotsianidis I, Hatzimichael E, Spyridonidis A, Anargyrou K, Poulakidas E, Giannoullia P, Apostolidis I, Stamouli M, Konstantopoulos K, Pappa V, Panayiotidis P, Harhalakis N, Anagnostopoulos A, Angelopoulou M.

Hematol Oncol. 2018 Oct;36(4):645-650. doi: 10.1002/hon.2521. Epub 2018 Jun 8.

PMID:
29882363
15.

Long-term outcomes of total body irradiation plus cyclophosphamide versus busulfan plus cyclophosphamide as conditioning regimen for acute lymphoblastic leukemia: a comparative study.

Sakellari I, Gavriilaki E, Chatziioannou K, Papathanasiou M, Mallouri D, Batsis I, Bousiou Z, Bouziana S, Constantinou V, Douka V, Apostolou C, Iskas M, Lalayanni C, Athanasiadou A, Sotiropoulos D, Yannaki E, Gianouzakos V, Anagnostopoulos A.

Ann Hematol. 2018 Oct;97(10):1987-1994. doi: 10.1007/s00277-018-3383-9. Epub 2018 Jun 5.

PMID:
29869673
16.

Donor EBV at the time of hematopoietic cell transplantation: Is it time to adopt molecular assays?

Sakellari I, Papalexandri A, Mallouri D, Batsis I, Iskas M, Xochelli A, Marvaki A, Gavriilaki E, Vardi A, Zerva P, Touloumenidou T, Anagnostopoulos A.

J Clin Virol. 2018 May;102:32-33. doi: 10.1016/j.jcv.2018.02.012. Epub 2018 Feb 21. No abstract available.

PMID:
29482045
17.

Unraveling the Genetics of Transplant-Associated Thrombotic Microangiopathy: Lessons to be Learned.

Gavriilaki E, Sakellari I, Mallouri D, Batsis I, Yannaki E, Anagnostopoulos A.

Biol Blood Marrow Transplant. 2017 Nov;23(11):2013-2014. doi: 10.1016/j.bbmt.2017.07.018. Epub 2017 Jul 26. No abstract available.

18.

The Role of Low-dose Anti-thymocyte Globulin as Standard Prophylaxis in Mismatched and Matched Unrelated Hematopoietic Peripheral Stem Cell Transplantation for Hematologic Malignancies.

Sakellari I, Batsis I, Bousiou Z, Mallouri D, Constantinou V, Gavriilaki E, Smias C, Yannaki E, Kaloyannidis P, Papaioannou G, Stavroyianni N, Syrigou A, Sotiropoulos D, Fylaktou A, Tsompanakou A, Saloum R, Anagnostopoulos A.

Clin Lymphoma Myeloma Leuk. 2017 Oct;17(10):658-666. doi: 10.1016/j.clml.2017.06.008. Epub 2017 Jun 29.

PMID:
28716402
19.

Transplant-associated thrombotic microangiopathy: opening Pandora's box.

Gavriilaki E, Sakellari I, Anagnostopoulos A, Brodsky RA.

Bone Marrow Transplant. 2017 Oct;52(10):1355-1360. doi: 10.1038/bmt.2017.39. Epub 2017 Mar 13. Review.

PMID:
28287636
20.

Candida is an emerging pathogen beyond the neutropenic period of allogeneic hematopoietic cell transplantation.

Sakellari I, Gavriilaki E, Kaliou M, Mallouri D, Batsis I, Yannaki E, Smias C, Sotiropoulos D, Tsorlini E, Anagnostopoulos A.

Clin Transplant. 2017 Apr;31(4). doi: 10.1111/ctr.12921. Epub 2017 Feb 22. No abstract available.

PMID:
28224660
21.

Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience.

Angelopoulou MK, Vassilakopoulos TP, Batsis I, Sakellari I, Gkirkas K, Pappa V, Giannoulia P, Apostolidis I, Apostolopoulos C, Roussou P, Panayiotidis P, Dimou M, Kyrtsonis MC, Palassopoulou M, Vassilopoulos G, Moschogiannis M, Kalpadakis C, Margaritis D, Spyridonidis A, Michalis E, Anargyrou K, Repousis P, Hatzimichael E, Bousiou Z, Poulakidas E, Grentzelias D, Harhalakis N, Pangalis GA, Anagnostopoulos A, Tsirigotis P.

Hematol Oncol. 2018 Feb;36(1):174-181. doi: 10.1002/hon.2383. Epub 2017 Feb 20.

22.

Allogeneic hematopoietic cell transplantation for primary refractory acute lymphoblastic leukemia: A report from the Acute Leukemia Working Party of the EBMT.

Pavlů J, Labopin M, Zoellner AK, Sakellari I, Stelljes M, Finke J, Fanin R, Stuhler G, Afanasyev BV, Bloor AJ, Anagnostopoulos A, Mohty M, Giebel S, Nagler A.

Cancer. 2017 Jun 1;123(11):1965-1970. doi: 10.1002/cncr.30604. Epub 2017 Feb 17.

23.

Survival Advantage and Comparable Toxicity in Reduced-Toxicity Treosulfan-Based versus Reduced-Intensity Busulfan-Based Conditioning Regimen in Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients after Allogeneic Hematopoietic Cell Transplantation.

Sakellari I, Mallouri D, Gavriilaki E, Batsis I, Kaliou M, Constantinou V, Papalexandri A, Lalayanni C, Vadikolia C, Athanasiadou A, Yannaki E, Sotiropoulos D, Smias C, Anagnostopoulos A.

Biol Blood Marrow Transplant. 2017 Mar;23(3):445-451. doi: 10.1016/j.bbmt.2016.11.023. Epub 2016 Nov 30.

24.

Transplant-associated thrombotic microangiopathy: an unresolved complication of unrelated allogeneic transplant for hematologic diseases.

Sakellari I, Gavriilaki E, Boussiou Z, Batsis I, Mallouri D, Constantinou V, Kaloyannidis K, Yannaki E, Bamihas G, Anagnostopoulos A.

Hematol Oncol. 2017 Dec;35(4):932-934. doi: 10.1002/hon.2346. Epub 2016 Sep 19. No abstract available.

PMID:
27641429
25.

Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?

Oliveira MC, Labopin M, Henes J, Moore J, Papa ND, Cras A, Sakellari I, Schroers R, Scherer HU, Cuneo A, Kyrcz-Krzemien S, Daikeler T, Alexander T, Finke J, Badoglio M, Simões B, Snowden JA, Farge D.

Bone Marrow Transplant. 2016 Jun;51(6):889. doi: 10.1038/bmt.2016.126. No abstract available.

PMID:
27245089
26.

Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?

Oliveira MC, Labopin M, Henes J, Moore J, Del Papa N, Cras A, Sakellari I, Schroers R, Scherer HU, Cuneo A, Kyrcz-Krzemien S, Daikeler T, Alexander T, Finke J, Badoglio M, Simões B, Snowden JA, Farge D.

Bone Marrow Transplant. 2016 Apr;51(4):501-5. doi: 10.1038/bmt.2015.299. Epub 2015 Dec 7. Erratum in: Bone Marrow Transplant. 2016 Jun;51(6):889.

PMID:
26642332
27.

A prospective study of incidence, clinical and quality of life consequences of oral mucositis post palifermin prophylaxis in patients undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation.

Sakellari I, Angelopoulou M, Tsopra O, Dervenoulas I, Tsirigotis P, Spyridonidis A, Liga M, Tsionos K, Anargyrou K, Pouli A, Anagnostopoulos A.

Ann Hematol. 2015 Oct;94(10):1733-40. doi: 10.1007/s00277-015-2437-5. Epub 2015 Jul 5.

PMID:
26141369
28.

Directed dewetting of amorphous silicon film by a donut-shaped laser pulse.

Yoo JH, In JB, Zheng C, Sakellari I, Raman RN, Matthews MJ, Elhadj S, Grigoropoulos CP.

Nanotechnology. 2015 Apr 24;26(16):165303. doi: 10.1088/0957-4484/26/16/165303. Epub 2015 Apr 1.

PMID:
25827170
29.

Carmustine, etoposide, cytarabine and melphalan versus a newly designed intravenous busulfan-based Busulfex, etoposide and melphalan conditioning regimen for autologous hematopoietic cell transplant: a retrospective matched-pair analysis in advanced Hodgkin and non-Hodgkin lymphomas.

Sakellari I, Mallouri D, Batsis I, Apostolou C, Konstantinou V, Abela EM, Douka V, Marvaki A, Karypidis K, Iskas M, Baliakas P, Kaloyannidis P, Yannaki E, Sotiropoulos D, Kouvatseas G, Smias C, Anagnostopoulos A.

Leuk Lymphoma. 2015;56(11):3071-81. doi: 10.3109/10428194.2015.1028054. Epub 2015 Apr 7.

PMID:
25760637
30.

Specific abnormalities versus number of abnormalities and cytogenetic scoring systems for outcome prediction after allogeneic hematopoietic SCT for myelodysplastic syndromes.

Kelaidi C, Tzannou I, Baltadakis I, Batsis I, Mallouri D, Spyridonidis A, Gigantes S, Tsirigotis P, Apostolidis I, Athanasiadou A, Manola K, Anagnostopoulos A, Harhalakis N, Sakellari I, Karakasis D.

Bone Marrow Transplant. 2014 Aug;49(8):1022-8. doi: 10.1038/bmt.2014.87. Epub 2014 May 5.

PMID:
24797183
31.

Silent T-cell lymphoma of γδ T-cell origin initially presented as panniculitis.

Patsatsi A, Koletsa T, Sotiriadis D, Batsis I, Sakellari I, Anagnostopoulos A, Papadaki T, Kostopoulos I.

J Eur Acad Dermatol Venereol. 2015 Jun;29(6):1244-5. doi: 10.1111/jdv.12477. Epub 2014 Mar 18. No abstract available.

PMID:
24641297
32.

Autologous HSCT for systemic sclerosis.

Sakellari I, Gavriilaki E, Mallouri D, Batsis I, Anagnostopoulos A.

Lancet. 2013 Jun 15;381(9883):2080. doi: 10.1016/S0140-6736(13)61240-4. No abstract available.

PMID:
23769229
33.

Molecular evidence for repertoire skewing of T large granular lymphocyte proliferation after allogeneic hematopoietic SCT: report of two cases.

Papalexandri A, Stalika E, Iskas M, Karypidou M, Zerva P, Touloumenidou T, Tachynopoulou V, Batsis I, Papadaki T, Sakellari I, Anagnostopoulos A, Stamatopoulos K.

Bone Marrow Transplant. 2013 Sep;48(9):1260-1. doi: 10.1038/bmt.2013.40. Epub 2013 Apr 22. No abstract available.

PMID:
23604008
34.

GVHD-associated chronic kidney disease after allogeneic haematopoietic cell transplantation.

Sakellari I, Barbouti A, Bamichas G, Mallouri D, Kaloyannidis P, Fragidis S, Batsis I, Apostolou C, Karpouza A, Yannaki E, Smias C, Sombolos K, Anagnostopoulos A.

Bone Marrow Transplant. 2013 Oct;48(10):1329-34. doi: 10.1038/bmt.2013.55. Epub 2013 Apr 15.

PMID:
23584436
35.

An unusual cluster of Acremonium kiliense fungaemias in a haematopoietic cell transplantation unit.

Ioakimidou A, Vyzantiadis TA, Sakellari I, Arabatzis M, Smias C, Douka V, Velegraki A, Anagnostopoulos A, Malissiovas N.

Diagn Microbiol Infect Dis. 2013 Mar;75(3):313-6. doi: 10.1016/j.diagmicrobio.2012.11.015. Epub 2013 Jan 3.

PMID:
23290506
36.

Diffusion-assisted high-resolution direct femtosecond laser writing.

Sakellari I, Kabouraki E, Gray D, Purlys V, Fotakis C, Pikulin A, Bityurin N, Vamvakaki M, Farsari M.

ACS Nano. 2012 Mar 27;6(3):2302-11. doi: 10.1021/nn204454c. Epub 2012 Feb 16.

PMID:
22324511
37.

Three-dimensional metallic photonic crystals with optical bandgaps.

Vasilantonakis N, Terzaki K, Sakellari I, Purlys V, Gray D, Soukoulis CM, Vamvakaki M, Kafesaki M, Farsari M.

Adv Mater. 2012 Feb 21;24(8):1101-5. doi: 10.1002/adma.201104778. Epub 2012 Jan 26.

PMID:
22278944
38.

Management of cutaneous T-Cell lymphoma patients with extracorporeal photopheresis. The Hellenic experience.

Siakantaris MP, Tsirigotis P, Stavroyianni N, Argyropoulos KV, Girkas K, Pappa V, Chondropoulos S, Papadavid E, Sakellari I, Anagnostopoulos A, Antoniou C, Dervenoulas J.

Transfus Apher Sci. 2012 Apr;46(2):189-93. doi: 10.1016/j.transci.2011.10.029. Epub 2011 Dec 16.

PMID:
22178592
39.

Extracorporeal photopheresis in refractory chronic graft-versus-host disease: the influence on peripheral blood T cell subpopulations. A study by the Hellenic Association of Hematology.

Tsirigotis P, Kapsimalli V, Baltadakis I, Kaloyannidis P, Karakasis D, Papalexandri A, Psarra E, Nosi E, Konsta E, Vikentiou M, Papageorgiou S, Sakellari I, Pappa V, Harhalakis N, Anagnostopoulos A, Dervenoulas J.

Transfus Apher Sci. 2012 Apr;46(2):181-8. doi: 10.1016/j.transci.2011.10.028. Epub 2011 Nov 23.

PMID:
22115608
40.

Extracorporeal photopheresis in the treatment of chronic graft-versus-host disease. The Hellenic experience: a study by the Hellenic association of hematology.

Tsirigotis P, Kaloyannidis P, Papalexandri A, Baltadakis I, Karakasis D, Batsis I, Sakellari I, Kitra V, Goussetis E, Papageorgiou S, Spyridonidis A, Graphakos S, Harhalakis N, Dervenoulas I, Anagnostopoulos A.

Transfus Apher Sci. 2012 Apr;46(2):173-80. doi: 10.1016/j.transci.2011.09.001. Epub 2011 Oct 28.

PMID:
22036202
41.

Outcomes of Hodgkin's lymphoma patients with relapse or progression following autologous hematopoietic cell transplantation.

Kaloyannidis P, Voutiadou G, Baltadakis I, Tsirigotis P, Spyridonidis A, Repousis P, Balta A, Tsimberis S, Karakasis D, Sakellari I, Dervenoulas I, Harhalakis N, Anagnostopoulos A.

Biol Blood Marrow Transplant. 2012 Mar;18(3):451-7. doi: 10.1016/j.bbmt.2011.07.020. Epub 2011 Jul 29.

42.

Autologous haematopoietic stem cell transplantation in a patient with refractory Crohn's disease.

Kountouras J, Sakellari I, Tsarouchas G, Tsiaousi E, Michael S, Zavos C, Anastasiadou K, Stergiopoulos C, Anagnostopoulos A.

J Crohns Colitis. 2011 Jun;5(3):275-6. doi: 10.1016/j.crohns.2011.03.004. Epub 2011 Mar 27. No abstract available.

PMID:
21575901
43.

Long-term results of stem cell transplantation for MS: a single-center experience.

Fassas A, Kimiskidis VK, Sakellari I, Kapinas K, Anagnostopoulos A, Tsimourtou V, Sotirakoglou K, Kazis A.

Neurology. 2011 Mar 22;76(12):1066-70. doi: 10.1212/WNL.0b013e318211c537.

PMID:
21422458
44.

Reversible painful oral mucosal hyperpigmentation following palifermin administration.

Kaloyannidis P, Papalexandri A, Papaemanouil E, Papaioannou M, Sakellari I.

Acta Haematol. 2010;124(3):185-7. doi: 10.1159/000318835. Epub 2010 Oct 21. No abstract available.

PMID:
20962520
45.

Outbreak of novel influenza A (H1N1) in an adult haematology department and haematopoietic cell transplantation unit: clinical presentation and outcome.

Lalayanni C, Sirigou A, Iskas M, Smias C, Sakellari I, Anagnostopoulos A.

J Infect. 2010 Sep;61(3):270-2. doi: 10.1016/j.jinf.2010.06.013. Epub 2010 Jun 30. No abstract available.

PMID:
20600296
46.

The impact of desferrioxamine postallogeneic hematopoietic cell transplantation in relapse incidence and disease-free survival: a retrospective analysis.

Kaloyannidis P, Yannaki E, Sakellari I, Bitzioni E, Athanasiadou A, Mallouri D, Anagnostopoulos A.

Transplantation. 2010 Feb 27;89(4):472-9. doi: 10.1097/TP.0b013e3181c42944.

PMID:
20177351
47.

Hematopoietic cell transplantation and emerging viral infections.

Chatzidimitriou D, Gavriilaki E, Sakellari I, Diza E.

J Med Virol. 2010 Mar;82(3):528-38. doi: 10.1002/jmv.21696. Review.

PMID:
20087928
48.

GVL effect in plasmacytoid DC leukemia/lymphoma.

Kaloyannidis P, Zomas A, Paterakis G, Vadikoliou C, Mallouri D, Sakkas L, Sakellari I.

Bone Marrow Transplant. 2010 May;45(5):961-2. doi: 10.1038/bmt.2009.270. Epub 2009 Oct 5. No abstract available.

PMID:
19802034
49.

Ultra-low shrinkage hybrid photosensitive material for two-photon polymerization microfabrication.

Ovsianikov A, Viertl J, Chichkov B, Oubaha M, MacCraith B, Sakellari I, Giakoumaki A, Gray D, Vamvakaki M, Farsari M, Fotakis C.

ACS Nano. 2008 Nov 25;2(11):2257-62. doi: 10.1021/nn800451w.

PMID:
19206391
50.

low body mass index is an independent risk factor for transplant-associated microangiopathy following total-body irradiation-based conditioning regimens.

Kaloyannidis P, Mallouri D, Hatziioannou K, Batsis I, Yannaki E, Papavasileiou P, Sakellari I.

Biol Blood Marrow Transplant. 2008 Sep;14(9):1076-1078. doi: 10.1016/j.bbmt.2008.05.022. No abstract available.

Supplemental Content

Loading ...
Support Center